Medicine guide

BIVALIRUDINA HIKMA

As listed in the register: BIVALIRUDINA HIKMA 250 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN INYECTABLE O PERFUSIÓN EFG

250 mg · polvo para concentrado para solución inyectable y para perfusión

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Bivalirudina
Made by
Hikma Farmaceutica (Portugal) S.A.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBlood, clotting and anaemiaB01AE06

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made byHikma Farmaceutica (Portugal) S.A.
Active substanceBivalirudina
Used inBlood, clotting and anaemia
Strength250 mg
Formpolvo para concentrado para solución inyectable y para perfusión
ClassificationB01AE06 · Blood, clotting and anaemia
Routevía intravenosa
MarketedNo — authorised but not currently marketed, according to the register
GenericYes — a generic medicine, according to the register
Name in the registerBIVALIRUDINA HIKMA 250 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN INYECTABLE O PERFUSIÓN EFG
Nº Registro90576

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.